The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 1, Pages 80
Publisher
MDPI AG
Online
2020-12-30
DOI
10.3390/cancers13010080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
- (2020) Connie Kang et al. DRUGS
- ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients
- (2019) János T. Fekete et al. INTERNATIONAL JOURNAL OF CANCER
- Clinicopathologic Significance of LAIR-1 Expression in Hepatocellular Carcinoma
- (2018) Xiaojie Wu et al. CURRENT PROBLEMS IN CANCER
- Heterogeneity of Tumour Infiltrating Lymphocytes (TILs) in Breast Cancer and its prognostic significance
- (2018) Maryam Althobiti et al. HISTOPATHOLOGY
- A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells
- (2018) Alexander Wolff et al. PLoS One
- Molecular Subtypes and Local-Regional Control of Breast Cancer
- (2018) Simona Maria Fragomeni et al. Surgical Oncology Clinics of North America
- Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells
- (2018) Mulugeta M. Zegeye et al. Cell Communication and Signaling
- Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy
- (2018) Marinos Tsiatas et al. Cancer Medicine
- HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
- (2018) Tiziana Triulzi et al. OncoImmunology
- Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
- (2018) Chitra Joseph et al. BREAST CANCER RESEARCH AND TREATMENT
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukocyte‑associated immunoglobulin‑like receptor�1 promotes tumorigenesis in RCC
- (2018) Kentaro Jingushi et al. ONCOLOGY REPORTS
- Expression of PD-L1 and prognosis in breast cancer: a meta-analysis
- (2017) Minghui Zhang et al. Oncotarget
- MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
- (2016) Andrew R Green et al. BRITISH JOURNAL OF CANCER
- Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
- (2016) Emad A Rakha et al. HISTOPATHOLOGY
- Clinical significance of leukocyte-associated immunoglobulin-like receptor-1 expression in human cervical cancer
- (2016) Yue Wang et al. Experimental and Therapeutic Medicine
- Leukocyte-associated immunoglobulin-like receptor-1 expressed in epithelial ovarian cancer cells and involved in cell proliferation and invasion
- (2015) Qizhi Cao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis
- (2015) X. Yu et al. Clinical & Translational Oncology
- Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia
- (2014) O. Perbellini et al. HAEMATOLOGICA
- Updated UK Recommendations for HER2 assessment in breast cancer
- (2014) Emad A Rakha et al. JOURNAL OF CLINICAL PATHOLOGY
- Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
- (2014) Y. Yuan Journal of the Royal Society Interface
- Collagen as a double-edged sword in tumor progression
- (2013) Min Fang et al. TUMOR BIOLOGY
- bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
- (2013) P. Jezequel et al. Database-The Journal of Biological Databases and Curation
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- CD8+T lymphocytes infiltrating breast cancer
- (2012) Sahar Mahmoud et al. OncoImmunology
- Tumour-infiltrating macrophages and clinical outcome in breast cancer
- (2011) S M A Mahmoud et al. JOURNAL OF CLINICAL PATHOLOGY
- Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1
- (2011) Tomasz P. Rygiel et al. MOLECULAR IMMUNOLOGY
- MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
- (2010) Sahar M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis
- (2009) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
- (2009) Hany Onsy Habashy et al. BREAST CANCER RESEARCH AND TREATMENT
- The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer
- (2008) Alexandra Giatromanolaki et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started